Navigation Links
Neighborhood Smiles Launches a Groundbreaking Cavity Prevention Program for Their Patients
Date:3/29/2013

(PRWEB) March 29, 2013

Dental decay is the number one chronic disease affecting American youth; surpassing both obesity and asthma. For Dr.'s Kelley and Morgan those statistics are no longer daunting. They have taken the top caries research in the world and implemented a cavity prevention program developed by CariFree that is shown to decrease incidents of tooth decay by up to 74%. The system is known as CAMBRA or Caries Management by Risk Assessment. The team states: "We base all treatment plans on individual Risk Factors. Patients with high risk to decay are those on medications which dry the mouth, soda drinkers, and patients with acidic bacteria. With CariFree, we can combat these acid attacks, and sometimes reverse the effects of early decay. Now that is exciting!"

CAMBRA is rooted in a medical model of risk assessment. It requires the dental professional to assess each and every patient’s risk factors for the disease and then develop a personalized treatment plan to systematically lower their risk. The CariFree diagnostic tools leverage biofilm testing (to determine the levels of cavity-causing bacteria in the patient’s mouth) as well as a risk assessment questionnaire to determine the overall statistical probability a patient will develop new cavities over the next 12 months. Never before has such predictive information been available. Patients can then measurably lower their risk for decay by utilizing professional products and behavior modification.

Patients can expect the entire process to take a few minutes in their appointment. They will answer targeted questions regarding their current habits (eating and drinking, medication use, chronic health issues etc.) as well as undergo a quick, painless swab of their lower teeth (to determine if they have an excess of cavity causing bacteria). Then based on the information gathered, their dental team will counsel them on an appropriate course of action to lower their risk. If professional products are recommended the practitioner will provide the patient with a professional kit of product specifically designed to counteract their risk factors.

Science has proven that this disease cannot be stopped by the drill and fill approach. True cure requires a medical approach and a comprehensive assessment of each patient. This Neighborhood Smiles office has taken a bold and caring step for their patients and community.

For more information on the CariFree system go to http://www.carifree.com. Call now and make your screening appointment at: 505-225-1116.

About the doctors:
Dr. Kelley received his Bachelor’s degree in Zoology from Idaho State University. He continued his education by receiving his Doctor of Dental Surgery degree from Marquette University School of Dentistry. During his time at Marquette, Dr. Kelley served as the Class President for four years, and was the Student Body President his senior year. In addition to Student Government, he also served as the Ethics Committee Chairman for his school’s American Student Dental Association Chapter.

He is a certified Doctor of Dental Surgery and is a member of both the American Dental Association (ADA) and the Academy of General Dentistry (AGD).

Dr. Morgan completed his undergraduate studies at Brigham Young University where he received his BA in Spanish Translation. Following that he studied at Marquette University School of Dentistry where he completed his DDS degree. He is currently a member of the American Dental Association and the American Academy of Implant Dentistry.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10577425.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BIOWATER Wastewater Treatment Package Plant Arrives in Residential Neighborhoods
2. Dr. Timothy Rauch of Albuquerque, New Mexico Launches a Groundbreaking Cavity Prevention Program
3. CellHealth Institute Launches with Support from Influential Investors
4. Dr. Richard Charmoy Launches Groundbreaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
5. Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
6. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
7. Rockingham County Economic Development Launches New Website
8. Neogen launches rapid tests for ractopamine
9. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
10. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
11. Darrow Wealth Management Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, Inc. has received ... SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. The adjunctive seizure ... periods of rest. A lightweight, non-invasive monitor is placed on the belly of ...
(Date:2/23/2017)...  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing ... that Linda Marbán, Ph.D, president and chief executive officer, is ... Cowen and Company 37th Annual Health Care Conference ... Boston, MA 29th Annual ROTH ... pm ET) Dana Point, CA ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:1/30/2017)... Jan. 30, 2017   Invitae Corporation (NYSE: ... genetic information companies, today announced that it will report ... provide 2017 guidance on Monday, February 13, 2017, and ... day at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... will briefly review financial results, guidance, and recent developments ...
(Date:1/24/2017)... -- It sounds simple and harmless—an electronic sensor attached ... and alerts parents on their smart phones if, ... But pediatric experts argue that such devices may ... of medical benefits, especially to healthy babies. ... of healthy babies, promising peace of mind about ...
Breaking Biology News(10 mins):